Results 131 to 140 of about 13,076 (262)
Transnational career advantages: earnings growth of Japanese self-initiated expatriates. [PDF]
Ishida K.
europepmc +1 more source
Supply Chain Network, ESG Scores and Financial Performance
ABSTRACT This paper provides novel evidence on the role of supply chain networks in influencing firms' environmental, social and governance (ESG) scores and financial performance. Our analysis employs financial, board, ESG and supply chain data, resulting in an unbalanced panel of over 16,000 firm‐year observations from 3028 publicly traded US firms ...
Michail Filippidis +2 more
wiley +1 more source
Evaluation of Corporate Social Responsibility Practices in the Turkish Pharmaceutical Industry. [PDF]
Azak Sungur S +2 more
europepmc +1 more source
ABSTRACT Climate‐related risks and opportunities have become a central concern for companies as climate change increasingly affects business models, value chains, and long‐term competitiveness. However, limited evidence exists about how corporations confront the attendant practical and strategic challenges of climate‐related risk and opportunity ...
Sebastian Rhein +3 more
wiley +1 more source
Public-private partnerships for seed industry development in developing countries: Lessons from MasAgro maize in Mexico. [PDF]
Domínguez C +6 more
europepmc +1 more source
ABSTRACT As businesses are increasingly integrating circular economy (CE) principles to promote concrete sustainability actions, understanding which managerial aspects may align with this change becomes paramount. Employing a conceptual framework based on Cognitive‐Affective Personality System (CAPS) and Organizational Support theories, this study ...
Fiorenza Meucci +3 more
wiley +1 more source
China's Pharmaceutical Ascent: Opportunity for Global Health, Test for US Leadership. [PDF]
Babul A, Mahdavi P, Hussain M, Babul N.
europepmc +1 more source
ABSTRACT As global environmental concerns intensify, firms are increasingly expected to embed environmental responsibility into their core strategies. However, uncertainty remains over whether eco‐friendly initiatives are economically rewarded, reflecting ambiguity in consumers' true environmental preferences.
Kimitaka Nishitani +6 more
wiley +1 more source
Impact of China's Drug Regulatory Reforms on the Development of Anti-Tumor Drugs. [PDF]
Tang L, Yuan L, Geng Y, Yang Z, Huang G.
europepmc +1 more source
Too Complex to Control? How Firms Navigate Scope 3 Governance Under Institutional Uncertainty
ABSTRACT As Scope 3 emissions make up the largest share of many firms' carbon footprints, firms face growing pressure to manage emissions beyond their direct control. Ongoing revisions of the CSRD, the GHG Protocol, and the SBTi Net‐Zero Standard further increase regulatory and methodological uncertainty.
Victoria Fohrer +2 more
wiley +1 more source

